LAHORE: The Lahore High Court (LHC) restrained the Punjab government from proceeding further on a purchase order for supply of insulin to public hospitals and sought replies from the respondents.

Justice Ayesha A. Malik issued a stay on a petition by the Getz Pharmaceutical Company, challenging the change of conditions for the tender after shortlisting process.

Advocate Raheel Kamran Sheikh, the counsel for the company, argued that the respondent authorities had imposed the condition of providing biosimilarity studies in the technical specification of the tender for drugs/medicines and medical devices. He alleged that the requirement of biosimilarity studies had not been provided for in the rules and it was a condition catered specifically to enable a respondent pharma company, namely Novo Nordisk Pharma, to participate and succeed in the bidding process.

The counsel argued that the condition was tailor made to exclude the petitioner/company as the respondent/company was the sole agent for a foreign supplier that might have the capacity to provide biosimilarity studies for the product. He said the impugned condition eliminated the opportunity of fair competition.

The counsel pointed out that the petitioner agitated the matter before the government, which failed to decide the same in accordance with law.

Additional Advocate General Akhtar Javed, on behalf of the government, questioned the maintainability of the petition before the court. He said the petitioner had participated in the tendering process and resorted to litigation after the purchase order was issued to the respondent company.

The written order issued on Monday about Friday’s hearing on the petition said, “The respondents are restrained from proceeding further in the matter that is proceedings on the basis of the purchase order until next date of hearing.”

The judge also directed the respondents to submit their reports and parawise comments by Feb 17. The respondents also include the secretary health, director general health services and the Punjab Procurement Regulatory Authority.

Published in Dawn, February 11th, 2020

Opinion

Editorial

Holding the line
16 Mar, 2026

Holding the line

PAKISTAN’S long battle against polio has recently produced encouraging signs. Data from the national eradication...
Power self-reliance
Updated 16 Mar, 2026

Power self-reliance

PAKISTAN’S transition to domestic sources of electricity is a welcome development for a country that has long been...
Looking for safety
16 Mar, 2026

Looking for safety

AS the Middle East conflict enters its third week, the war’s most enduring victims are not those who wage it....
Battling hate
Updated 15 Mar, 2026

Battling hate

In the current scenario, geopolitical conflict, racial prejudice and religious bigotry all contribute to the threats Muslims face.
TB drugs shortage
15 Mar, 2026

TB drugs shortage

‘CRIMINAL negligence’ is the phrase that jumps to mind when one considers the disturbing consequences of the...
Chinese diplomacy
Updated 14 Mar, 2026

Chinese diplomacy

THERE are signs that China is taking a more active role in trying to resolve the issue of cross-border terrorism...